Vibsanine E (1), [now known as vibsanin E (1)] isolated by Kawazu 1 from the Japanese fish poison plant Viburnum odoratissimum (Sangoju) in 1978 ( Figure 1) , was amongst the first vibsane natural products to be isolated. Since this time an entire vibsane family has been isolated from the Viburnum species 2 as elucidated by Fukuyama, 3 Shen 4 and Duh. 5 Biological activity in this natural product family is prevalent, 3 for example, vibsanin A displayed piscicidal activity, vibsanin B inhibited rice seedling root growth, vibsanins B and C exhibited cytotoxic activities on KB cells, aldolvibsanin B showed lethal brine shrimp activity, vibsanin O demonstrated cytotoxicity against P-388 cells as did vibsanins P and W, vibsanin K exhibited cytotoxicity against human gastric (NUGC) and oral epidermoid (HONE-1) tumor cells, and vibsanins P and W were cytotoxic against A549 and HT-29 cells. Considering the amount of anti-cancer and cytotoxic activity displayed by the vibsane family of natural products, and our interest in the cancer field, 6 we were attracted to vibsanin E (1) as to-date its biological activity had not been reported. We embarked on firstly attempting to confirm the structure of vibsanin E (1) and secondly devise a route that would provide sufficient material for extensive biological evaluation.
Only very recently have vibsane natural product family members succumbed to total synthesis. So far, the synthesis of (±)-2-O-methylneovibsain H (2), 7 (±)-neovibsanin B (3) 8 and (−)-5-epi-vibsanin E (4) 9 ( Figure 2 ) have been achieved. The stereocontrol in these systems has been challenging, and on many occasions the synthetic efforts have resulted in formation of diastereomers of the natural products [i.e. (+)-6-epi-vibsanin F (5), 10 (±)-5,10bis-epi-vibsanin E (6), 11 and (±)-5,14-bis-epi-spirovibsanin A 12 ] or deadend synthetic explorations ( Figure 2 ). [13] [14] [15] [16] As vibsanin E (1) has a highly functionalized fused sevenmembered ring and is one of the original vibsanes, we consider it the pinnacle target in this family of natural products.
Both Williams and Davies have worked independently towards a total synthesis of vibsanin E (1). The Queensland group pursued a biogenetically modeled approach giving access to bicycle 8, 17, 18 which, although led to many advanced intermediates (i.e. 9), did not yield the target. 19, 20 The Davies group utilised three key cycloadditions to achieve a total synthesis of 5-epi-10-epi-vibsanin E 6; a rhodium-catalysed [4+3] and a subsequent heteronuclear [4+2] afforded bicycle 10, followed by a photochemically induced [4+2] (Scheme 1). 11 In the view that the Davies strategy readily provided multi-gram quantities of bicycle 10 11 and the Queensland group had significant end game experience with molecules of this type, 19 including the development of a novel method utilising ylid 11 for introducing the enol ester side chain, 20 it made sense to join forces in this common quest. In fact the initial fruits of this collaboration led to the first total synthesis of the natural product (−)-5-epi-vibsanin E (4) 9 in which many of the previous difficulties encountered with both introduction and stereocontrol of the side chains were overcome. Highlights of this successful pathway included, conjugate addition of an α-oxa methylene anion (i.e. MOMOCH 2 Li derived from MOMOCH 2 SnBu 3 ) 21 to bicycle 10, using TMSCl 22 activation, affording 12. Metallation then subsequent O-allylation of 12 afforded 13, which gave a mixture of epimers 14 and 15. Ketone 14 was then carried through a series of deprotection oxidation steps to provide aldehyde 16, which afforded (−)-5-epi-vibsanin E (4) on treatment with ylid 11 (Scheme 2).
At the time, however, considerable difficulties were being encountered with the Claisen rearrangement in that the anti-isomer 15 was only obtained in low yield preventing a synthesis of vibsanin E (1), but also a considerable amount of by-product 17 was being observed (Scheme 3). If this could be overcome a total synthesis of vibsanin E (1) would be possible.
After considerable experimentation it was discovered that C-allylated material 17 could be significantly reduced if the microwave induced Claisen rearrangement was performed in a dilute solution [i.e. toluene (0.02M)]. In addition it was also found that the syn-isomer 14 could be epimerised to the anti-isomer 15 in 51% (K 2 CO 3 /MeOH), with further material obtained on recycling. With these developments the anti-isomer 15 could be obtained in 44% yield (56% with recovery) and reasonable quanitity. Subjecting 15 to the same deprotection oxidation sequence used for (−)-5-epi-vibsanin E (4) (see scheme 2) afforded aldehyde 18. Treatment of 18 with ylid 11 produced vibsanin E (1), 23 which was an identical 1 H and 13 C NMR spectroscopic match to the natural material, 24 albeit accompanied by trace amounts of the tentatively assigned by-product 19 (Scheme 4).
In conclusion, vibsanin E (1), a structurally rare complex diterpene, has been efficiently synthesised in 14 steps confirming the proposed relative stereochemistry. The synthesis combines the rhodium catalyzed [4+3] cycloaddition strategy to rapidly generate the tricyclic core with an effective end game strategy to introduce the remaining side-chains. This represents the first total synthesis of Vibsanin E (1), 31 years since it was isolated, and paves the way for derivative synthesis should structure activity studies be deployed. Vibsanin E (1) is currently undergoing biological evaluation, results of which will be reported in due course. Vibsanin, and epi-vibsanin, family members that have previously been synthesised.
